Form 4: TransUnion EVP Granted 11,776 Restricted Stock Units
Insider Transaction Report
TransUnion's EVP, CHRO, Alicia Brooke Zuiker, was granted 11,776 restricted stock units, vesting over three years.
Summary
- Alicia Brooke Zuiker, Executive Vice President and Chief Human Resources Officer (EVP, CHRO) of TransUnion (TRU), was granted 11,776 shares of common stock.
- The transaction date for this grant was February 27, 2026.
- These shares represent a grant of restricted stock units (RSUs) with a price of $0 per share, indicating they are part of an equity compensation plan.
- Following this transaction, Ms. Zuiker beneficially owns 57,455 shares of TransUnion common stock directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term shareholder value and retention.
Positives
- The grant of 11,776 restricted stock units aligns the executive's interests with long-term shareholder value through multi-year vesting.
- Equity compensation is a standard practice for retaining and incentivizing key management personnel.
Negatives
- No direct negatives are apparent from this standard Form 4 filing, which primarily reports an executive compensation transaction.
Future Outlook
The grant of restricted stock units indicates a long-term incentive structure for a key executive, with vesting scheduled through August 2029, suggesting continued commitment and alignment with future company performance.
Industry Context
StockSavvy.ai notes that equity grants, particularly restricted stock units with multi-year vesting schedules, are a common and widely accepted practice in the financial services and data analytics industry for executive compensation, aiming to align management incentives with long-term shareholder value creation and executive retention.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) as a component of executive compensation is standard across major U.S. corporations, including peers in the credit reporting and data analytics sector such as Experian and Equifax.
- A three-year ratable vesting schedule is typical for such grants, comparable to practices observed at companies like Visa or Mastercard for their executive equity awards, ensuring long-term retention and performance alignment.
Stakeholder Impact
- Shareholders: The grant of RSUs aims to align executive interests with long-term shareholder value, potentially leading to improved company performance.
- Employees: Standard executive compensation practices can signal stability and a structured approach to talent retention within the company.
Next Steps
- The restricted stock units will vest in three tranches: 33% on August 27, 2027, 33% on August 27, 2028, and 34% on August 27, 2029.
Key Dates
| Date | Description |
|---|---|
| 02/27/2026 | Date of grant for 11,776 restricted stock units. |
| 03/03/2026 | Date the Form 4 filing was signed. |
| 08/27/2027 | First vesting date for 33% of the restricted stock units. |
| 08/27/2028 | Second vesting date for 33% of the restricted stock units. |
| 08/27/2029 | Third and final vesting date for 34% of the restricted stock units. |
Recommendation
holdThis Form 4 filing reports a routine executive equity grant and does not contain information that would fundamentally alter the investment thesis for TransUnion. It's an expected compensation event, not a signal for significant price movement, thus a 'hold' recommendation is appropriate based solely on this filing.
Keywords
TransUnion, TRU, SEC Form 4, Restricted Stock Units, RSU Grant, Executive Compensation, Alicia Brooke Zuiker, Insider Transaction, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.